RXHOMEO HOMEOPATHIC COMBO 3 KIT [RXHOMEO PRIVATE LIMITED D.B.A.]

RXHOMEO HOMEOPATHIC COMBO 3 KIT [RXHOMEO PRIVATE LIMITED D.B.A.]
PDF | XML

NDC 15631-2453-0
Set ID 648c4e7c-6bc1-4b79-aca4-484235ab2632
Category HUMAN OTC DRUG LABEL
Packager Rxhomeo Private Limited d.b.a.
Generic Name
Product Class
Product Number
Application Number
  • ACTIVE INGREDIENT

    BADIAGA HPUS 2X and higher


    KALI SULPHURICUM HPUS 1X and higher

  • USES

    A homeopathic combination pack with two single remedies Badiaga and Kali Sulphuricum for treatment of dandruff.


    Badiaga: Badiaga has marked action in treating dandruff. There is soreness of scalp with dry and tetter like dandruff. Pain in forehead and temple extending to eye balls with blueness under eyes.

    Kali Sulphuricum: Kali Sulph also helps in seborrhoea or dandruff and ringworm of scalp or beard with abundant scales. Sores on skin with thick, profuse, yellow watery secretion. Bald spots after gonorrhea.

  • INDICATIONS

    Condition listed above or as directed by the physician

  • DOSAGE

    Adults: Take 4-5 pellets or tablets orally by mouth and allow them to dissolve on tongue. Repeat at least 3 times a day, about 30 minutes before or after food. Similarly take the second remedy after a gap of 30 minutes, make sure to remember the sequence.

    Children: Half of the adult dose.

  • WARNINGS

    This product is to be used for self-limiting conditions

    If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional

    Keep this and all medication out of reach of children

    Do not use if capseal is broken or missing.

    Close the cap tightly after use.

  • INACTIVE INGREDIENTS

    Sucrose for Pellets.

    Lactose for Tablets.

  • STORAGE

    Store in a cool dark place

  • QUESTIONS OR COMMENTS

    www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com
    Rxhomeo, Inc 1504 Fairway Dr. Ste W 100 Lewisville, TX 75057 USA

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    image description

  • INGREDIENTS AND APPEARANCE
    RXHOMEO HOMEOPATHIC COMBO 3 
    rxhomeo homeopathic combo 3 kit
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:15631-2453
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:15631-2453-01 in 1 CONTAINER10/21/2016
    Quantity of Parts
    Part #Package QuantityTotal Product Quantity
    Part 1
    Part 2
    Part 1 of 2
    BADIAGA 
    badiaga pellet
    Product Information
    Item Code (Source)NDC:15631-0070
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SPONGILLA LACUSTRIS (UNII: 6SZ0G98BHM) (SPONGILLA LACUSTRIS - UNII:6SZ0G98BHM) SPONGILLA LACUSTRIS2 [hp_X]
    Inactive Ingredients
    Ingredient NameStrength
    SUCROSE (UNII: C151H8M554)  
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic
    Part 2 of 2
    KALI SULPHURICUM 
    kali sulphuricum tablet
    Product Information
    Item Code (Source)NDC:15631-0613
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POTASSIUM SULFATE (UNII: 1K573LC5TV) (SULFATE ION - UNII:7IS9N8KPMG) POTASSIUM SULFATE1 [hp_X]
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE (UNII: J2B2A4N98G)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize3mm
    FlavorImprint Code
    Contains    
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic10/21/2016
    Labeler - Rxhomeo Private Limited d.b.a. (650833994)
    Establishment
    NameAddressID/FEIBusiness Operations
    Rxhomeo Private Limited d.b.a.,Rxhomeo, Inc650833994manufacture(15631-2453) , label(15631-2453)

Related Drugs